NUREXONE BIOLOGIC INC (NRXBF:OTCMKTS)
$0.35642 -0.13318 (-27.2018%)
Analysed NUREXONE BIOLOGIC INC (NRXBF:OTCMKTS) News Sources
NurExone to Participate in Water Tower Research Insights Conference on April 14, 2026
10-04-2026
yahoo.com
NurExone Biologic Inc. Announces Fourth Quarter and Full-Year 2025 Financial Results and Provides Corporate Update
16-04-2026
yahoo.com
NRXBF Worth a Look at This Stage
17-04-2026
yahoo.com
Australian Patent Granted to NurExone Covering Stem Cell-Derived Exosome Production
27-04-2026
yahoo.com
NurExone Advances to Stage 2 of EU-Backed EIT Health Catapult Programme 2026
14-05-2026
yahoo.com
NurExone Receives Notice of Patent Grant in South Korea Covering ExoPTEN Technology
19-05-2026
yahoo.com
NurExone Announces First Quarter 2026 Financial Results and Provides Corporate Update
01-06-2026
yahoo.com
EXCLUSIVE: France Based NurExone Targets Mexico Wellness Market With Exosome Supply Agreement
24-06-2026
yahoo.com
Exo-Top, NurExone’s wholly owned U.S. Subsidiary, Enters Into Binding MOU For Naïve Exosome Distribution in Mexico
24-06-2026
yahoo.com
NurExone Announces Closing of Non-Brokered Private Placement
30-06-2026
yahoo.com
What is the current price of NUREXONE BIOLOGIC INC (NRXBF:OTCMKTS)?
The current price of NUREXONE BIOLOGIC INC (NRXBF:OTCMKTS) is $0.35642.
NUREXONE BIOLOGIC INC (NRXBF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of NUREXONE BIOLOGIC INC (NRXBF:OTCMKTS) since the previous trading day is $-0.13318.
NUREXONE BIOLOGIC INC (NRXBF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of NUREXONE BIOLOGIC INC (NRXBF:OTCMKTS) since the previous trading day is -27.2018%.
What is the most recent average sentiment score for NUREXONE BIOLOGIC INC (NRXBF:OTCMKTS)?
The most recent average sentiment score for NUREXONE BIOLOGIC INC (NRXBF:OTCMKTS) is 67 out of 100.
What is the most recent average sentiment for NUREXONE BIOLOGIC INC (NRXBF:OTCMKTS)?
The most recent sentiment for NUREXONE BIOLOGIC INC (NRXBF:OTCMKTS) is .
SEC-8K** Filing Available For NUREXONE BIOLOGIC INC (NRXBF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.